Found: 40
Select item for more details and to access through your institution.
Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0171639
- By:
- Publication type:
- Article
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma group.
- Published in:
- Acta Gastro-Enterologica Belgica, 2017, v. 80, n. 4, p. 481
- By:
- Publication type:
- Article
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 10, p. 2574, doi. 10.1038/bjc.2013.648
- By:
- Publication type:
- Article
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 7, p. 1717, doi. 10.1038/bjc.2013.524
- By:
- Publication type:
- Article
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 4, p. 909, doi. 10.1038/bjc.2013.442
- By:
- Publication type:
- Article
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study.
- Published in:
- British Journal of Cancer, 2012, v. 107, n. 4, p. 639, doi. 10.1038/bjc.2012.328
- By:
- Publication type:
- Article
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region.
- Published in:
- 2010
- By:
- Publication type:
- journal article
High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Prognosis and predictive value of KIT exon 11 deletion in GISTs.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Incidence and prognostic value of tumour cells detected by RT–PCR in peripheral blood stem cell collections from patients with Ewing tumour.
- Published in:
- British Journal of Cancer, 2006, v. 95, n. 10, p. 1326, doi. 10.1038/sj.bjc.6603438
- By:
- Publication type:
- Article
Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome.
- Published in:
- British Journal of Cancer, 2006, v. 94, n. 7, p. 1066, doi. 10.1038/sj.bjc.6603037
- By:
- Publication type:
- Article
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51211-y
- By:
- Publication type:
- Article
High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin’s lymphomas: a single center experience on 18 patients.
- Published in:
- Bone Marrow Transplantation, 1998, v. 21, n. 1, p. 51, doi. 10.1038/sj.bmt.1701046
- By:
- Publication type:
- Article
Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generation.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 3, p. 254, doi. 10.1007/s00262-005-0040-7
- By:
- Publication type:
- Article
Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 7, p. 2286, doi. 10.1245/s10434-019-07421-9
- By:
- Publication type:
- Article
L'organisation française en réseau de soins pour la prise en charge des sarcomes.
- Published in:
- Oncologie (Tech Science Press), 2016, v. 18, n. 4, p. 247, doi. 10.1007/s10269-016-2615-7
- By:
- Publication type:
- Article
Standards, Options: Recommandations pour I’indication des agents stimulant l’érythropoïèse (ASE: époétine alpha, époétine bêta et darbépoétine) dans la prise en charge de l’anémie en cancérologie (mise à jour 2007), rapport abrégé
- Published in:
- Oncologie (Tech Science Press), 2008, v. 10, n. 2, p. 160, doi. 10.1007/s10269-008-0832-4
- By:
- Publication type:
- Article
Standards, Options et Recommandations 2006. Prise en charge des patients adultes atteints de sarcome des tissus mous, de sarcome utérin ou de tumeur stromale gastro-intestinale.
- Published in:
- Oncologie (Tech Science Press), 2007, v. 9, n. 2, p. 173, doi. 10.1007/s10269-007-0599-z
- By:
- Publication type:
- Article
Thérapeutiques moléculaires ciblées des sarcomes des tissus mous: actualités et perspectives.
- Published in:
- Oncologie (Tech Science Press), 2007, v. 9, n. 2, p. 131, doi. 10.1007/s10269-006-0529-5
- By:
- Publication type:
- Article
L’ESMO et la formation médicale en cancérologie.
- Published in:
- Oncologie (Tech Science Press), 2007, v. 9, n. 1, p. 37, doi. 10.1007/s10269-006-0590-0
- By:
- Publication type:
- Article
Toxicité cutanée des anti-EGF-R.
- Published in:
- Oncologie (Tech Science Press), 2006, v. 8, n. 10, p. 889, doi. 10.1007/s10269-006-0534-8
- By:
- Publication type:
- Article
Anticorps anti-VEGF: un emploi universel?
- Published in:
- Oncologie (Tech Science Press), 2006, v. 8, n. 9, p. 808, doi. 10.1007/s10269-006-0520-1
- By:
- Publication type:
- Article
Le traitement des causes du cancer.
- Published in:
- Oncologie (Tech Science Press), 2006, v. 8, n. 9, p. 795, doi. 10.1007/s10269-006-0531-y
- By:
- Publication type:
- Article
Nouvelles approches dans les thérapeutiques ciblées: les récepteurs des facteurs de croissance de type insuline et les cyclines.
- Published in:
- Oncologie (Tech Science Press), 2006, v. 8, n. 9, p. 835, doi. 10.1007/s10269-006-0540-x
- By:
- Publication type:
- Article
Tumeurs rares malignes de l’ovaire.
- Published in:
- Oncologie (Tech Science Press), 2005, v. 7, n. 7, p. 556, doi. 10.1007/s10269-005-0286-x
- By:
- Publication type:
- Article
Les sarcomes.
- Published in:
- Oncologie (Tech Science Press), 2004, v. 6, n. 5, p. 340, doi. 10.1007/s10269-004-0083-y
- By:
- Publication type:
- Article
Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathways.
- Published in:
- Cell Death Discovery, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41420-020-00302-1
- By:
- Publication type:
- Article
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
- Published in:
- British Journal of Cancer, 2003, v. 88, n. 11, p. 1721, doi. 10.1038/sj.bjc.6600956
- By:
- Publication type:
- Article
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy.
- Published in:
- 2003
- By:
- Publication type:
- journal article
A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.
- Published in:
- British Journal of Cancer, 2001, v. 85, n. 6, p. 816, doi. 10.1054/bjoc.2001.2011
- By:
- Publication type:
- Article
Osteosarcoma.
- Published in:
- British Journal of Cancer, 2001, v. 84, p. 78, doi. 10.1054/bjoc.2000.1770
- By:
- Publication type:
- Article
Renal cell carcinoma induces interleukin 10 and prostaglandin E<sub>2</sub> production by monocytes.
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 1, p. 119
- By:
- Publication type:
- Article
Targeted polytherapy in small cell sarcoma and its association with doxorubicin.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 8, p. 1458, doi. 10.1016/j.molonc.2014.05.016
- By:
- Publication type:
- Article
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 3, p. 316, doi. 10.1111/j.1365-2141.2007.06661.x
- By:
- Publication type:
- Article